China’s Ascletis Shares Surge on Oral Weight-Loss Drug Data
Ascletis Pharma Shares Surge on Drug Results Ascletis Pharma Inc. shares surged Tuesday, posting their biggest rally since April, after mid-stage results for its oral weight-loss drug suggested a potential best-in-class profile. Key Details The positive movement followed the release of promising mid-stage trial results for the company’s oral weight-loss treatment. Image: Road Trip with…